Kākāpō Parrot: Genomic sequencing benefits Conservation programme

Kākāpō parrot (also known as “owl parrot” because of its owl-like facial features) is a critically endangered parrot species native to New Zealand. It is an unusual animal for it is the longest living birds in the world (may live up to 90 years of age). Weighing about 3-4 Kg, it is also the heaviest, only flightless and nocturnal parrot in the world.  

https://youtu.be/X3J6YaEc9zo?list=TLGG8G5rC5D_iW8yOTA4MjAyMw

Kākāpō inhabited New Zealand since their evolution in isolation but their population declined rapidly. In 1970s, only 18 male kākāpō were known to exist. Existence of female Kākāpō were confirmed in 1980. Thanks to Intensive conservation management, Kākāpō parrots have been brought from the brink of extinction. Their number was 51 in 1995. Today, 247 kākāpō are alive1,2.  

To assist conservation, Kākāpō125+ project came into being in 2015 to sequence the genomes of 125 living kākāpō plus some important recently deceased individuals. The idea was to improve genetic management of kākāpō, particularly to address low reproductive output (infertility) and disease that was hindering recovery. The full chromosome-level assembly of the reference genome of an individual kākāpō was completed in 20183.  

In a study published on 29th August 2023, the research team has reported sequencing the genomes of nearly the entire kākāpō population (as of 2018) of 169 kākāpō, from 125 living individuals and 44 stored samples. The population level data associate genetic diversity across the species to specific DNA sequences linked to traits such as disease susceptibility, chick growth etc. This could help identify health risks earlier to plan treatment customised to individual kākāpō bird. This approach to identify specific genetic features crucial to survival could be repurposed to manage conservation of other endangered species4,5.  

*** 

References:  

  1. Department of Conservation. Govt of NZ. Kākāpō Recovery. Available at  https://www.doc.govt.nz/our-work/kakapo-recovery/ 
  1. Natural History Museum. New Zealand’s quirky kākāpō are pulled back from the edge of extinction. https://www.nhm.ac.uk/discover/new-zealands-quirky-kakapo-are-pulled-back-from-extinction.html 
  1. Department of Conservation. Govt of NZ. Kākāpō125+ gene sequencing https://www.doc.govt.nz/our-work/kakapo-recovery/what-we-do/research-for-the-future/kakapo125-gene-sequencing/ 
  1. University of Otago 2023.  News – Saving species from extinction – high-quality kākāpō population sequencing provides breakthrough in understanding key conservation genetics. Available at https://www.otago.ac.nz/news/otago0247128.html Acessed on 29 August 2023.  
  1. Guhlin, J., Le Lec, M.F., Wold, J. et al. Species-wide genomics of kākāpō provides tools to accelerate recovery. Nat Ecol Evol (2023). https://doi.org/10.1038/s41559-023-02165-y  Preprint at bioRxiv doi: https://doi.org/10.1101/2022.10.22.513130  

*** 

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

Selegiline’s Wide Array of Potential Therapeutic Effects

Selegiline is an irreversible monoamine oxidase (MAO) B inhibitor1....

Earth Observation data from Space to help adaption to challenges of Climate change

UK Space Agency will support two new projects. The...

B.1.1.529 variant named Omicron, designated as a Variant of concern (VOC) by WHO

WHO’s Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) was...

Drug Trials for COVID-19 Begins in the UK and USA

Clinical Trials to evaluate effectiveness of anti-malarial drug, hydroxychloroquine...

Urine Test for Early Detection of Lung Cancer 

Researchers have developed a urine test that can detect...

A Step Towards Cure for Greying and Baldness

Researchers have identified a group of cells in the...
Umesh Prasad
Umesh Prasad
Umesh Prasad is a researcher-communicator who excels at synthesizing peer-reviewed primary studies into concise, insightful, and well-sourced public articles. A specialist in knowledge translation, he is driven by a mission to make science inclusive for non-English speaking audiences. Toward this goal, he founded “Scientific European,” this innovative, multilingual, open-access digital platform. By addressing a critical gap in global science dissemination, Prasad acts as a key knowledge curator whose work represents a sophisticated new era of scholarly journalism, bringing the latest research to the doorstep of common people in their native languages.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...